Understanding Patient and Family Experience in Pediatric Hemato-Oncology
Published November 5, 2026
Background. Patient- and family-reported experience is a vital indicator of healthcare quality, particularly in pediatric hematology-oncology. This study assessed patient- and family-reported experience and identified its sociodemographic, clinical, and organizational determinants in a newly established pediatric hemato-oncology department of a tertiary university hospital in Morocco. Methods. A cross-sectional survey was conducted between November 2023 and January 2024. Experience was assessed using a validated multidimensional questionnaire covering reception and access, information and communication, human and relational aspects of care, therapeutic management and pain control, accommodation conditions, and logistical and administrative processes. Sociodemographic and clinical variables were collected; bivariate analyses and multivariate logistic regression identified factors associated with overall satisfaction; internal consistency was evaluated using Cronbach’s alpha. Results. Three hundred patients were included (response rate 97.08%; mean age 9.03 ± 4.89 years). Overall satisfaction was very high (98.3%), and most respondents would recommend the service. Satisfaction was higher among families living closer to the hospital, with medical coverage, scheduled admission, and cancer rather than hematologic disease, while dissatisfaction was mainly linked to waiting times, administrative complexity, unclear staff roles, and poor meal quality. In multivariate analysis, cancer diagnosis, follow-up longer than one year, planned admission, and waiting time under two hours were independently associated with higher odds of satisfaction (adjusted ORs = 2.86, 2.44, 3.85, and 2.44, respectively); the questionnaire showed good reliability (Cronbach’s alpha = 0.85). Conclusions. Despite very high reported satisfaction, organizational and logistical factors remain critical levers to further enhance patient and family experience in pediatric hemato-oncology.
Related content
-
Quality & Clinical Excellence
Tell Me 3: Aligning Quality, Safety, and Experience Through Dialogue
Published February 17, 2026
“Tell Me 3” is a continuous improvement initiative to promote clear, consistent conversations about new medications, focusing on the name, purpose, and potential side effects. By integrating these discussions into daily workflows, the initiative strengthens patient understanding and drives a culture of quality and safety. This webinar highlights practical tools including the “Tell Me 3”
Learn more -
Quality & Clinical Excellence
Evaluating Quality of Care Under Nigeria’s National Health Insurance Scheme
Published November 5, 2026
Objective: Patient narratives provide in-depth insights of user quality ratings of healthcare delivery but are underutilized. The assessment of patient satisfaction often relies on survey data based on quantifiable indicators. While quantifiable indicators provide a snapshot of patient perceptions of the care they receive, they tend to gloss over pertinent details to understand their experiences
Learn more -
Quality & Clinical Excellence | Staff & Provider Engagement
Three Strategies to Improve Inpatient PX Performance
Published October 20, 2026
Patient Experience, now more than ever, is a team sport. It needs true collaboration between hospital executive, physician, and nursing leadership to impact our patients’ experience and build trust in the healthcare system. Performance depends on consistent, reliable communication at the bedside and across interdisciplinary care teams. Learn how Bon Secours St. Mary’s Hospital identified
Learn more